Back
China Resources Building Materials Technology Holdings 10K Form
Sell
37
CARCY
China Resources Building Materials Technology Holdings
Last Price:
7.04
Seasonality Move:
-2.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CARCY News And Ratings
See the #1 stock for the next 7 days that we like better than CARCY
CARCY Financial Statistics
Sales & Book Value
| Annual Sales: | $3.61B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $26.73 |
| Price / Book: | 0.27 |
Profitability
| EPS (TTM): | 0.08210 |
|---|---|
| Net Income (TTM): | $19.17M |
| Gross Margin: | $531.83M |
| Return on Equity: | 10.73% |
| Return on Assets: | 4.63% |
China Resources Building Materials Technology Holdings Earnings Forecast
Key China Resources Building Materials Technology Holdings Financial Ratios
- The Gross Profit Margin over the past 16 years for CARCY is 14.72%.
- The Selling, General & Administrative Expenses for CARCY have been equal to 11.07% of Gross Profit Margin.
- The Interest Expense is 83.22% of Operating Income.
- The Net Earning history of CARCY is 2.52% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 7 years.
China Resources Building Materials Technology Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Current Symbol: | CARCY |
| Website: | crcement.com |
Debt
| Debt-to-Equity Ratio: | 0.57 |
|---|---|
| Current Ratio: | 0.77 |
| Quick Ratio: | 0.66 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.04 |
|---|---|
| Forward P/E Ratio: | 0 |
CARCY Technical Analysis vs Fundamental Analysis
Sell
37
China Resources Building Materials Technology Holdings (CARCY)
is a Sell
Is China Resources Building Materials Technology Holdings a Buy or a Sell?
-
China Resources Building Materials Technology Holdings stock is rated a Sell
The current China Resources Building Materials Technology Holdings [CARCY] share price is $7.04. The Score for CARCY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.